Related Experiment Videos
The diagnosis and treatment of hypertensive crises
1The University of Texas Health Science Center at Houston, Houston, TX, USA. joseph.varon@uth.tmc.edu
Insights
Hypertensive crises require prompt BP reduction, with immediate IV treatment for emergencies and oral agents for urgencies. Newer agents like clevidipine offer advantages over toxic older drugs in managing hypertensive crises.
Area of Science:
- Cardiology
- Nephrology
- Emergency Medicine
Background:
- Hypertension (HTN) affects millions, with hypertensive crises defined by severe blood pressure (BP) elevation (>180/120 mm Hg).
- Hypertensive crises are classified as emergencies (with end-organ damage) or urgencies (without).
- The main goal is safe BP reduction, with immediate intervention critical for hypertensive emergencies.
Purpose of the Study:
- To differentiate hypertensive emergencies from urgencies based on BP levels and end-organ damage.
- To outline appropriate treatment strategies for hypertensive crises, emphasizing timely BP reduction.
- To evaluate the efficacy and safety of various intravenous (IV) antihypertensive agents.
Main Methods:
- Review of existing literature on hypertensive crisis management.
- Categorization of hypertensive crises into emergencies and urgencies.
- Analysis of available rapid-acting IV antihypertensive agents for efficacy and toxicity.
Main Results:
- Hypertensive emergencies necessitate immediate BP reduction with titratable IV agents in an ICU setting.
- Hypertensive urgencies are typically managed with oral antihypertensive medications.
- Clevidipine is highlighted as a newer agent with advantages, while sodium nitroprusside, nifedipine, nitroglycerin, and hydralazine are associated with significant toxicities and are not recommended as first-line therapies.
Conclusions:
- Effective management of hypertensive crises hinges on accurate diagnosis and appropriate BP reduction strategies.
- Intravenous agents like clevidipine are preferred for hypertensive emergencies due to efficacy and safety profiles.
- Avoiding toxic agents like sodium nitroprusside is crucial for optimal patient outcomes in hypertensive emergencies.
Abstract:
Hypertension (HTN) is one of the most common chronic medical conditions, affecting nearly 72 million people in the United States. A systolic blood pressure (BP) > 180 mm Hg or a diastolic BP > 120 mm Hg is considered a "hypertensive crisis." Hypertensive crises are categorized as either hypertensive emergencies or urgencies depending on the degree of BP elevation and presence of end-organ damage. The primary goal of intervention in a hypertensive crisis is to safely reduce BP. Immediate reduction in BP is required only in patients with acute end-organ damage (ie, hypertensive emergency). This requires treatment with a titratable shortacting intravenous (IV) antihypertensive agent, while severe HTN with no acute end-organ damage (ie, hypertensive urgency) is usually treated with oral antihypertensive agents. Patients with hypertensive emergencies are best treated in an intensive care unit (ICU) with titratable IV hypotensive agents. Rapid-acting IV antihypertensive agents are available, including clevidipine, labetalol, esmolol, fenoldopam, nicardipine, and sodium nitroprusside. Newer agents such as clevidipine have considerable advantages compared with other available agents in the management of hypertensive crises. Sodium nitroprusside is an extremely toxic drug, and its use in the treatment of hypertensive emergencies should be avoided. Likewise, nifedipine, nitroglycerin, and hydralazine should not to be considered first-line therapies in the management of hypertensive crises because these agents are associated with significant toxicities and/or side effects.
Related Concept Videos
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Acute Coronary Syndrome IV: Interprofessional Care